Creative Planning
PRME icon

Creative Planning’s Prime Medicine PRME Stock Holding History

Creative Planning’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.6K Sell
21,295
-6,951
-25% -$23.1K ﹤0.01% 4076
2026
Q1 		$98.3K Buy
28,246
+10,354
+58% +$39.4K ﹤0.01% 3907
2025
Q4 		$62.1K Sell
17,892
-5,190
-22% -$23.1K ﹤0.01% 3779
2025
Q3 		$128K Buy
23,082
+12,937
+128% +$52.6K ﹤0.01% 3630
2025
Q2 		$25.1K Buy
+10,145
New +$15.6K ﹤0.01% 3582
2025
Q1 		– Sell
-27,623
Closed -$80.7K – 3670
2024
Q4 		$80.7K Buy
+27,623
New +$97K ﹤0.01% 3186

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Creative Planning's PRME Position: Q2 2026 in Review

Creative Planning reduced its Prime Medicine (PRME) stake by 25% in Q2 2026, selling an estimated $23.1K and leaving 21,295 shares worth $78.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4076.

Creative Planning first reported a position in PRME in Q4 2024 and has held it in 6 quarters since. The position peaked at $128K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Creative Planning held 21,295 shares of Prime Medicine worth $78.6K as of Q2 2026.
  • Creative Planning sold 6,951 Prime Medicine shares in Q2 2026, an estimated $23.1K.
  • Prime Medicine made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #4076 holding.
  • Creative Planning first reported a position in Prime Medicine in Q4 2024 and has held it in 6 quarters since.
  • Creative Planning's Prime Medicine position peaked at $128K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.